AK

Anita Kukreja

Director Director DIN 01396161
DIN 01396161 First appointment May 2007 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2007
Shareholding value β€’β€’β€’β€’ Premium profile

About Anita Kukreja

Data last updated:

Anita Kukreja was a Director at Xenon Pharma Private Limited (2007) and Director at Mascot Health Series Private Limited (2007–2022). The companies operate in Pharma.

DIN 01396161
Primary Designation Director
Industry Pharma
First Appointment 31 May 2007

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Xenon Pharma Private Limited U24233DL2005PTC139951
Director27 Jul 20072005₹19.65 Cr (FY 2024)Active
Mascot Health Series Private Limited U74999DL2007PTC164204
Director31 May 20072007₹404 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Xenon Pharma Private Limited
Mascot Health Series Private Limited
Premium access

Shareholding and investment profile for Anita Kukreja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anita Kukreja

Anita Kukreja was first appointed on 31 May 2007 as Director at Mascot Health Series Private Limited.

Anita Kukreja held 2 earlier board appointments: Xenon Pharma Private Limited (Director, 27 Jul 2007 to 25 Sep 2007); Mascot Health Series Private Limited (Director, 31 May 2007 to 10 Dec 2022).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available